Suppr超能文献

纳洛酮在平衡麻醉后作为麻醉拮抗剂的应用

Naloxone as narcotic antagonist after balanced anaesthesia.

作者信息

Tigerstedt I

出版信息

Acta Anaesthesiol Scand. 1977;21(6):481-8. doi: 10.1111/j.1399-6576.1977.tb01249.x.

Abstract

Different modes of naloxone administration were studied in 100 patients following N2O-O2-relaxant anaesthesia, where fentanyl was administered for analgesia according to a standardized dose schedule (mean 4.3 microgram/kg/h). After reversal of muscular relaxation, the patients were randomly given naloxone--either 1.0 or 2.5 microgram/kg i.v. or 2.5 or 5.0 microgram/kg i.m., or none (control). Each group consisted of 20 patients. Awakening was fastest after 2.5 microgram/kg i.v. of naloxone (1.8 +/- 0.1 min), the time being significantly shorter (P less than 0.025) than in the control group (2.7 +/- 0.4 min). After 15 min, the minute volume and frequency of respiration were significantly higher (P less than 0.05) in all naloxone groups than in the control group. However, the arterialized venous PCO2 did not show significant differences during the recovery. It is therefore suggested that naloxone reversal may cause an increase in CO2 production. The immediate postoperative pain (score 0-3) was mildest in the control group (1.0 mean) and severest after 2.5 microgram/kg i.v. of naloxone (1.8 mean); the difference was statistically significant (P less than 0.05). The groups receiving 1.0 microgram/kg i.v. and 2.5 microgram/kg i.m. did not differ from each other (1.2 mean). Nausea and vomiting were reported more often after 5.0 microgram/kg im. of naloxone than in other groups. After moderate doses of fentanyl during balanced anaesthesia, routine use of naloxone does not seem to be necessary, but if rapid recovery is essential, 1.0 microgram/kg i.v. or 2.5 microgram/kg i.m. of naloxone may be recommended and these doses do not cause a higher incidence of side effects.

摘要

在100例接受N₂O - O₂ - 肌松药麻醉的患者中研究了不同的纳洛酮给药方式,这些患者按照标准化剂量方案(平均4.3微克/千克/小时)给予芬太尼用于镇痛。肌肉松弛逆转后,患者被随机给予纳洛酮——静脉注射1.0或2.5微克/千克,或肌肉注射2.5或5.0微克/千克,或不给予(对照组)。每组由20名患者组成。静脉注射2.5微克/千克纳洛酮后苏醒最快(1.8±0.1分钟),该时间显著短于(P<0.025)对照组(2.7±0.4分钟)。15分钟后,所有纳洛酮组的每分通气量和呼吸频率均显著高于(P<0.05)对照组。然而,恢复过程中动脉化静脉血PCO₂未显示出显著差异。因此提示纳洛酮逆转可能导致二氧化碳生成增加。术后即刻疼痛(评分0 - 3)在对照组最轻(平均1.0),静脉注射2.5微克/千克纳洛酮后最严重(平均1.8);差异具有统计学意义(P<0.05)。静脉注射1.0微克/千克和肌肉注射2.5微克/千克的组之间无差异(平均1.2)。肌肉注射5.0微克/千克纳洛酮后恶心和呕吐的报告发生率高于其他组。在平衡麻醉期间给予中等剂量芬太尼后,常规使用纳洛酮似乎没有必要,但如果快速恢复至关重要,可推荐静脉注射1.0微克/千克或肌肉注射2.5微克/千克纳洛酮,且这些剂量不会导致更高的副作用发生率。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验